Total Payments
$8,039
2024 Payments
$705.80
Companies
44
Transactions
283
Medicare Patients
5,045
Medicare Billing
$493,100
Payment Breakdown by Category
Food & Beverage$6,668 (82.9%)
Travel$1,364 (17.0%)
Education$7.38 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,668 | 279 | 82.9% |
| Travel and Lodging | $1,364 | 3 | 17.0% |
| Education | $7.38 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,209 | 14 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $888.40 | 48 | $0 (2024) |
| Boston Scientific Corporation | $463.43 | 15 | $0 (2023) |
| HEARTFLOW, INC. | $401.13 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $386.97 | 22 | $0 (2024) |
| Amgen Inc. | $356.28 | 18 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $317.88 | 15 | $0 (2024) |
| Medtronic Vascular, Inc. | $306.49 | 6 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $293.18 | 15 | $0 (2024) |
| PFIZER INC. | $269.74 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $705.80 | 33 | Novartis Pharmaceuticals Corporation ($139.68) |
| 2023 | $1,118 | 48 | Novartis Pharmaceuticals Corporation ($224.63) |
| 2022 | $1,355 | 52 | Inari Medical, Inc. ($208.67) |
| 2021 | $887.58 | 44 | Novartis Pharmaceuticals Corporation ($185.29) |
| 2020 | $380.67 | 14 | Edwards Lifesciences Corporation ($138.16) |
| 2019 | $272.55 | 19 | PFIZER INC. ($111.90) |
| 2018 | $446.20 | 18 | Medtronic Vascular, Inc. ($140.20) |
| 2017 | $2,872 | 55 | Edwards Lifesciences Corporation ($2,029) |
All Payment Transactions
283 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $26.54 | General |
| Category: Cardiology | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/19/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $19.79 | General |
| Category: Coronary | ||||||
| 11/11/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Genetic Disease | ||||||
| 10/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: DIABETES | ||||||
| 10/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Cardio-renal | ||||||
| 09/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/03/2024 | Thrombolex, Inc. | Bashir Endovascular Catheter (Device) | Food and Beverage | Cash or cash equivalent | $11.10 | General |
| Category: Cardiovascular | ||||||
| 08/29/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $12.74 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/14/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Cardio-renal | ||||||
| 08/08/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $20.89 | General |
| Category: Cardiology | ||||||
| 08/01/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $19.72 | General |
| 07/30/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/26/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: Genetic Disease | ||||||
| 07/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/14/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $24.02 | General |
| Category: Cardiology | ||||||
| 06/06/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/05/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: DIABETES | ||||||
| 05/08/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Cardiology | ||||||
| 05/01/2024 | Thrombolex, Inc. | Bashir Endovascular Catheter (Device) | Food and Beverage | Cash or cash equivalent | $21.56 | General |
| Category: Cardiovascular | ||||||
| 04/26/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/25/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $90.12 | General |
| Category: Coronary | ||||||
| 04/11/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $25.70 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,400 | 1,906 | $291,829 | $144,987 |
| 2022 | 22 | 1,090 | 1,442 | $236,134 | $111,774 |
| 2021 | 20 | 1,024 | 1,339 | $207,574 | $103,240 |
| 2020 | 20 | 1,531 | 1,873 | $362,818 | $133,099 |
Total Patients
5,045
Total Services
6,560
Medicare Billing
$493,100
Procedure Codes
95
All Medicare Procedures & Services
95 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 201 | 393 | $73,914 | $36,519 | 49.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 52 | 52 | $33,060 | $17,861 | 54.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 91 | 97 | $25,156 | $13,051 | 51.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 61 | 128 | $21,952 | $11,974 | 54.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 85 | 85 | $24,621 | $11,884 | 48.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 81 | 81 | $19,856 | $9,802 | 49.4% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 52 | 103 | $17,201 | $7,724 | 44.9% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 40 | 160 | $12,640 | $6,791 | 53.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 42 | 52 | $6,920 | $3,343 | 48.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 227 | 275 | $5,775 | $3,003 | 52.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 22 | 22 | $7,140 | $2,878 | 40.3% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 15 | 16 | $6,780 | $2,848 | 42.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 21 | $5,556 | $2,684 | 48.3% |
| 93241 | Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 13 | 13 | $5,031 | $2,660 | 52.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 20 | 21 | $5,547 | $2,373 | 42.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 35 | 37 | $4,285 | $2,313 | 54.0% |
| 93017 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) | Office | 2023 | 89 | 89 | $4,629 | $1,810 | 39.1% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 89 | 89 | $2,769 | $1,433 | 51.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 17 | 17 | $3,196 | $1,274 | 39.9% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 22 | 22 | $2,295 | $1,070 | 46.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $2,145 | $971.30 | 45.3% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 32 | 33 | $694.00 | $352.64 | 50.8% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 33 | 35 | $630.00 | $343.70 | 54.6% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2023 | 52 | 52 | $37.44 | $26.53 | 70.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 143 | 299 | $56,533 | $27,435 | 48.5% |
About Dr. Dhaval Shah, M.D
Dr. Dhaval Shah, M.D is a Internal Medicine healthcare provider based in Tempe, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2010. The National Provider Identifier (NPI) number assigned to this provider is 1588975643.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dhaval Shah, M.D has received a total of $8,039 in payments from pharmaceutical and medical device companies, with $705.80 received in 2024. These payments were reported across 283 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($6,668).
As a Medicare-enrolled provider, Shah has provided services to 5,045 Medicare beneficiaries, totaling 6,560 services with total Medicare billing of $493,100. Data is available for 4 years (2020–2023), covering 95 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease, Interventional Cardiology
- Location Tempe, AZ
- Active Since 06/23/2010
- Last Updated 07/17/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1588975643
Products in Payments
- ENTRESTO (Drug) $625.61
- FFRct (Device) $401.13
- LifeVest (Device) $317.88
- Repatha (Biological) $306.21
- XARELTO (Drug) $247.83
- LEQVIO (Drug) $242.59
- JARDIANCE (Drug) $229.98
- BRILINTA (Drug) $223.76
- FLOWTRIEVER CATHETER, S (Device) $208.67
- WATCHMAN Access System (Device) $173.05
- ELIQUIS (Drug) $171.28
- CoreValve Evolut (Device) $138.16
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $138.16
- VERQUVO (Drug) $133.25
- WATCHMAN (Device) $131.09
- GENERAL ATHERECTOMY (Device) $114.13
- Assure WCD (Device) $107.37
- CHANTIX (Drug) $100.79
- MITRACLIP (Device) $76.60
- WAINUA (Drug) $76.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Tempe
Jeffrey Hoodin, M.d, M.D
Internal Medicine — Payments: $206,801
Internal Medicine $206,801
Dr. Robert Bloomberg, Md, MD
Internal Medicine — Payments: $13,899
Internal Medicine $13,899
Dr. Carlos Echevarria, Md, Mmm, MD, MMM
Internal Medicine — Payments: $13,214
Internal Medicine $13,214
Dr. Kenneth Anaeme, Md, MD
Internal Medicine — Payments: $10,337
Internal Medicine $10,337
Dr. Shilpa Bhatnagar, M. D, M. D
Internal Medicine — Payments: $7,050
Internal Medicine $7,050
Dr. Shobha Parvathala, M. D, M. D
Internal Medicine — Payments: $7,018
Internal Medicine $7,018